MPWM Advisory Solutions’s AbbVie ABBV Stock Holding History

MPWM Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	478 +209	+78%	+$45K	0.06%	136
2026 Q1	$58.4K	Buy	269 +176	+189%	+$39K	0.03%	181
2025 Q4	$21.3K	Hold	93	–	–	0.01%	246
2025 Q3	$21.6K	Hold	93	–	–	0.01%	230
2025 Q2	$17.2K	Hold	93	–	–	0.01%	249
2025 Q1	$19.4K	Buy	93 +1	+1%	+$194	0.01%	240
2024 Q4	$16.4K	Buy	+92	New	+$16.9K	0.01%	272

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MPWM Advisory Solutions's ABBV Position: Q2 2026 in Review

MPWM Advisory Solutions increased its AbbVie (ABBV) stake by 78% in Q2 2026, buying an estimated $45K and bringing the position to 478 shares worth $120K. The position accounts for 0.06% of the portfolio, ranked #136.

MPWM Advisory Solutions first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MPWM Advisory Solutions held 478 shares of AbbVie worth $120K as of Q2 2026.
MPWM Advisory Solutions bought 209 AbbVie shares in Q2 2026, an estimated $45K.
AbbVie made up 0.06% of MPWM Advisory Solutions's portfolio in Q2 2026, its #136 holding.
MPWM Advisory Solutions first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MPWM Advisory Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.